Stay updated on ARO-C3 in Renal Disease Clinical Trial

Sign up to get notified when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-C3 in Renal Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:04.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added 'IgA glomerulonephritis' to the list of conditions on the study page.
    Difference
    0.1%
    Check dated 2026-04-02T15:40:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added 'Complement 3 glomerulopathy' as a condition term and removed 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' from the disease terminology.
    Difference
    0.1%
    Check dated 2026-03-26T11:45:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a revision note for v3.5.0. The previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:15:40.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:50:14.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page adds a disease term 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis' and a Genetic and Rare Diseases Information Center resource, and deletes an old funding notice and revision note. These updates are informational and do not alter the study's design or displayed results.
    Difference
    0.6%
    Check dated 2026-02-18T16:33:07.000Z thumbnail image

Stay in the know with updates to ARO-C3 in Renal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-C3 in Renal Disease Clinical Trial page.